Solis Mammography (PRIVATE.SOLIS)

Overall impact
B (65)

Commentary

Solis Mammography is a strong overall performer. With a 'B' rating of 65.0 for overall impact (73rd percentile compared to all companies), Solis Mammography ranks 94th out of 248 industry peers, behind Cerba Healthcare, HealthPRO Heritage, Clario and 90 others, and ahead of GenesisCare, Allied Physicians Group, Southern Veterinary Partners and 151 others. On top material causes for Solis Mammography's industry (Health Care Providers & Services), Solis Mammography performs well in Technology Innovation (94.9 score), Child and Maternal Health (95.4), Accountable Institutions (87.2) and 32 other causes where it received an 'A' score and performs poorly in Fair Labor Practices (38.6 score), Decent, Safe Work Opportunities (32.7), Decent, Safe Work Opportunities (32.7) and 16 other causes where it received a 'D' or 'F' score.
Impact
Cause PRIVATE.SOLIS
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company

Solis Mammography

Employees
652
Sector
Health Care
Industry
Health Care Providers & Services
Sub-industry
Health Care Services
SASB industry
Health Care Delivery
Headquarters
#<Country/State:0x00007fef59294b68>, United States
Share classes
PRIVATE.SOLIS
Description
Provider of breast screening and diagnostic services dedicated to helping women achieve and maintain breast health. The company offers screening, diagnostic and three-dimensional (3D) mammography, breast ultrasound and biopsy, bone densitometry and molecular breast imaging, enabling patients to get oncology treatments and cures.
Material causes
Ethos considers the following causes material for Solis Mammography, based on its industry sub-industry Health Care Services. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.